Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics

Nature Reviews Gastroenterology and Hepatology

Volumn 14, Issue 8, 2017, Pages 491-502

  Gibson, Glenn R ^a   Hutkins, Robert ^b   Sanders, Mary Ellen ^c   Prescott, Susan L ^d   Reimer, Raylene A ^e   Salminen, Seppo J ^f   Scott, Karen ^g   Stanton, Catherine ^h   Swanson, Kelly S ⁱ   Cani, Patrice D ^j   Verbeke, Kristin ^k   Reid, Gregor ^l  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c International Scientific Association for Probiotics and Prebiotics   (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF TURKU   (Finland)

^g ROWETT RESEARCH INSTITUTE   (United Kingdom)

^h TEAGASC FOOD RESEARCH CENTRE   (Ireland)

ⁱ UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^j UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^k UNIVERSITY OF LEUVEN   (Belgium)

^l UNIVERSITY OF WESTERN ONTARIO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; INULIN; LACTULOSE; PREBIOTIC AGENT; PROBIOTIC AGENT;

CONSENSUS; CONSUMER; HEALTH CARE PERSONNEL; HUMAN; MEDICAL EXPERT; MICROFLORA; MOLECULAR EVOLUTION; NONHUMAN; NUTRITION; PRIORITY JOURNAL; PUBLISHING; REVIEW; RISK BENEFIT ANALYSIS; SCIENTIFIC LITERATURE; SCIENTIST; SOCIAL MEDIA; STANDARD; CONSENSUS DEVELOPMENT; HEALTH CARE ORGANIZATION; NOMENCLATURE;

HUMANS; PREBIOTICS; PROBIOTICS; SOCIETIES, SCIENTIFIC; TERMINOLOGY AS TOPIC;

EID: 85027283029     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2017.75     Document Type: Review

References (156)

1. Prescott, S. L., Logan, A. C., Millstein, R. A., Katszman, M. A. Biodiversity, the human microbiome and mental health: Moving toward a new clinical ecology for the 21st Century Int. J. Biodiversity 2016, 2718275 (2016).
2. David, L. A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563 (2014).
3. Cani, P. D., Everard, A. Talking microbes: When gut bacteria interact with diet and host organs. Mol. Nutr. Food Res. 60, 58-66 (2016).
4. Gibson, G. R., Roberfroid, M. B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 125, 1401-1412 (1995).
5. Collins, S., Reid, G. Distant site effects of ingested prebiotics. Nutrients 8, E523 (2016).
6. Propst, E. L., et al. A dose-response experiment evaluating the effects of oligofructose and inulin on nutrient digestibility, stool quality, and fecal protein catabolites in healthy adult dogs. J. Anim. Sci. 81, 3057-3066 (2003).
7. Park, S. H., Lee, S. I., Ricke, S. C. Microbial populations in naked neck chicken ceca raised on pasture flock fed with commercial yeast cell wall prebiotics via an Illumina MiSeq platform. PLoS ONE 11, e0151944 (2016).
8. Rettger, L. F., Cheplin, H. A. A. Treatise on the Transformation of the Intestinal Flora: With Special Reference to the Implantation of Bacillus acidophilus Vol. 13 (Yale Univ. Press, 1921).
9. Dubos, R., et al. Indigenous, normal, and autochthonous flora of the gastrointestinal tract. J. Exp. Med. 122, 67-76 (1965).
10. Savage, D. C. Microbial ecology of the gastrointestinal tract. Ann. Rev. Microbiol. 31, 107-133 (1977).
11. Food and Agricultural Organization of the United Nations, World Health Organization. Probiotics in food: Health and nutrition properties and guidelines for evaluation. FAO http://www.fao.org/3/a-a0512e.pdf (2006).
12. Hill, C., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506-514 (2014).
13. Simpson, H. L., Campbell, B. J. Review article: Dietary fibre-microbiota interactions. Aliment. Pharmacol. Ther. 42, 158-179 (2015).
14. Depeint, F., Tzortzis, G., Vulevic, J., l'Anson, K., Gibson, G. R. Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: A randomized, double-blind, crossover, placebo-controlled intervention study. Am. J. Clin. Nutr. 87, 785-791 (2008).
15. Costabile, A., et al. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br. J. Nutr. 104, 1007-1011 (2010).
16. Roberfroid, M., et al. Prebiotic effects: Metabolic and health benefits. Br. J. Nutr. 104 (Suppl. 2), S1-S63 (2010).
17. Schrezenmeir, J., de Vrese, M. Probiotics, prebiotics, and synbiotics-approaching a definition. Am. J. Clin. Nutr. 73, 361S-364S (2001).
18. Gibson, G. R., Probert, H. M., Loo, J. V., Rastall, R. A., Roberfroid, M. B. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr. Res. Rev. 17, 259-275 (2004).
19. Pineiro, M., et al. FAO technical meeting on prebiotics. J. Clin. Gastroenterol. 42, S156-S159 (2008).
20. Gibson, G. R., et al. Dietary prebiotics: Current status and new definition. Food Sci. Tech. Bull. Funct. Food 7, 1-19 (2010).
21. Bindels, L. B., Delzenne, N. M., Cani, P. D., Walter, J. Towards a more comprehensive concept for prebiotics. Nat. Rev. Gastroenterol. Hepatol. 12, 303-310 (2015).
22. Dewulf, E. M., et al. Insight into the prebiotic concept: Lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62, 1112-1121 (2013).
23. Hutkins, R. W., et al. Prebiotics: Why definitions matter. Curr. Opin. Biotechnol. 37, 1-7 (2016).
24. Louis, P., Flint, H. J., Michel, C. How to manipulate the microbiota: Prebiotics. Adv. Exp. Med. Biol. 902, 119-142 (2016).
25. Shannahan, F. Fibre man meets microbe man. Am. J. Clin. Nutr. 10, 1-2 (2015).
26. Verspreet, J., et al. A critical look at prebiotics within the dietary fiber concept. Ann. Rev. Food Sci. Technol. 7, 167-190 (2016).
27. Vandeputte, D., et al. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut http://dx.doi.org/10.1136/gutjnl-2016-313271 (2017).
28. Canfora, E. E., Jocken, J. W., Blaak, E. E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 11, 577-591 (2015).
29. Koh, A., De Vadder, F., Kovatcheva-Datchary, P., Backhed, F. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 165, 1332-1345 (2016).
30. Rastall, R. A., Gibson, G. R. Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health. Curr. Opin. Biotechnol. 32, 42-46 (2015).
31. Rastall, R. A. Functional oligosaccharides: Application and manufacture. Ann. Rev. Food Sci. Technol. 1, 305-339 (2010).
32. Sarbini, S., Rastall, R. A. Prebiotics: Metabolism, structure, and function. Func. Food Rev. 3, 93-106 (2011).
33. Goh, Y. J., Klaenhammer, T. R. Genetic mechanisms of prebiotic oligosaccharide metabolism in probiotic microbes. Ann. Rev. Food Sci. Technol. 6, 137-156 (2015).
34. Delcour, J. A., Aman, P., Courtin, C. M., Hamaker, B. R., Verbeke, K. Prebiotics, fermentable dietary fiber, and health claims. Adv. Nutr. 7, 1-4 (2016).
35. Ben David, Y., et al. Ruminococcal cellulosome systems from rumen to human. Environ. Microbiol. 17, 3407-3426 (2015).
36. Garrido, D., et al. Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria. Sci. Rep. 5, 13517 (2015).
37. Oozeer, R., et al. Intestinal microbiology in early life: Specific prebiotics can have similar functionalities as human-milk oligosaccharides. Am. J. Clin. Nutr. 98, 561S-571S (2013).
38. De Leoz, M. L. A., et al. Human milk glycomics and gut microbial genomics in infant feces show a correlation between human milk oligosaccharides and gut microbiota: A proof-of-concept study. J. Proteome Res. 14, 491-502 (2015).
39. Rockova, S., et al. Inter-species differences in the growth of bifidobacteria cultured on human milk oligosaccharides. Folia Microbiol. 57, 321-324 (2012).
40. He, Y., Lawlor, N. T., Newburg, D. S. Human milk components modulate Toll-like receptor-mediated inflammation. Adv. Nutr. 7, 102-111 (2016).
41. Kulinich, A., Liu, L. Human milk oligosaccharides: The role in the fine-tuning of innate immune responses. Carbohydr. Res. 432, 62-70 (2016).
42. Morrow, A. L., Ruiz-Palacios, G. M., Jiang, X., Newburg, D. S. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J. Nutr. 135, 1304-1307 (2005).
43. Charbonneau, M. R., et al. Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition. Cell 164, 859-871 (2016).
44. Marriage, B. J., Buck, R. H., Goehring, K. C., Oliver, J. S., Williams, J. A. Infants fed a lower calorie formula with 2FL show growth and 2FL uptake like breast-fed infants. J. Pediatr. Gastroenterol. Nutr. 61, 649-658 (2015).
45. Goehring, K. C., et al. Similar to those who are breastfed, infants fed a formula containing 2-fucosyllactose have lower inflammatory cytokines in a randomized controlled trial. J. Nutr. 146, 2559-2566 (2016).
46. Elison, E., et al. Oral supplementation of healthy adults with 2-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. Br. J. Nutr. 116, 1356-1368 (2016).
47. Underwood, M. A., German, J. B., Lebrilla, C. B., Mills, D. A. Bifidobacterium longum subspecies infantis: Champion colonizer of the infant gut. Pediatr. Res. 77, 229-235 (2015).
48. Charbonneau, M. R., et al. A microbial perspective of human developmental biology. Nature 535, 48-55 (2016).
49. Clifford, M. N. Diet-derived phenols in plasma and tissues and their implications for health. Planta Med. 70, 1103-1114 (2004).
50. Duenas, M., et al. A survey of modulation of gut microbiota by dietary polyphenols. Biomed. Res. Int. 2015, 850902 (2015).
51. O'Keefe, S. J. Diet, microorganisms and their metabolites, and colon cancer. Nat. Rev. Gastroenterol. Hepatol. 13, 691-706 (2016).
52. Pluznick, J. L. Gut microbiota in renal physiology: Focus on short-chain fatty acids and their receptors. Kidney Int. 90, 1191-1198 (2016).
53. Boets, E., et al. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: A stable isotope study. J. Physiol. 595, 541-555 (2017).
54. Canani, R. B., et al. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J. Gastroenterol. 17, 1519-1528 (2011).
55. McMillan, A., et al. A multi-platform metabolomics approach identifies highly specific biomarkers of bacterial diversity in the vagina of pregnant and non-pregnant women. Sci. Rep. 5, 14174 (2015).
56. Vulevic, J., et al. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons. Br. J. Nutr. 114, 586-595 (2015).
57. de Preter, V., et al. Baseline microbiota activity and initial bifidobacteria counts influence responses to prebiotic dosing in healthy subjects. Aliment. Pharmacol. Ther. 27, 504-513 (2008).
58. Albert, A. Y., et al. A study of the vaginal microbiome in healthy Canadian women utilizing cpn60-based molecular profiling reveals distinct Gardnerella subgroup community state types. PLoS ONE 10, e0135620 (2015).
59. Korshonov, V. M., et al. Study of vaginal bifidoflora of women of reproductive age [Russian]. Zh. Microbiol. Epidemiol. Immunobiol. 4, 74-78 (1999).
60. Antonio, M. A., Rabe, L. K., Hillier, S. L. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J. Infect. Dis. 3, 394-398 (2005).
61. Joyce, S. A., Gahan, C. G. Bile acid modifications at the microbe-host interface: Potential for nutraceutical and pharmaceutical interventions in host health. Ann. Rev. Food Sci. Technol. 7, 313-333 (2016).
62. Kuo, S. M., Merhige, P. M., Hagey, L. R. The effect of dietary prebiotics and probiotics on body weight, large intestine indices, and fecal bile acid profile in wild type and IL10/mice. PLoS ONE 8, e60270 (2013).
63. Savignac, H. M., et al. Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-levels in male mice. Brain Behav. Immunol. 52, 120-131 (2016).
64. de Cossió, L. F., et al. Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome. Brain Behav. Immunol. http://dx.doi.org/10.1016/j.bbi.2016.12.022 (2016).
65. Malaguarnera, M., et al. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. Eur. J. Gastroenterol. Hepatol. 22, 199-206 (2010).
66. Madhok, V., Futamura, M., Thomas, K. S., Barbarot, S. What's new in atopic eczema An analysis of systematic reviews published in 2012 and 2013. Part 2. Treatment and prevention. Clin. Exp. Dermatol. 40, 349-354 (2015).
67. Moro, G., et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child. 91, 814-819 (2006).
68. Hong, K. B., et al. Photoprotective effects of galacto-oligosaccharide and/or Bifidobacterium longum supplementation against skin damage induced by ultraviolet irradiation in hairless mice. Int. J. Food Sci. Nutr. 66, 923-930 (2015).
69. Gao, Z., Tseng, C. H., Strober, B. E., Pei, Z., Blaser, M. J. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS ONE 3, e2719 (2008).
70. Paulino, L. C., Tseng, C. H., Strober, B. E., Blaser, M. J. Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J. Clin. Microbiol. 44, 2933-2941 (2006).
71. Campananti, A., et al. A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. Ann. Oncol. 23, 1081-1082 (2012).
72. Everard, A., et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 8, 2116-2130 (2014).
73. Paul, H. A., Bomhof, M. R., Vogel, H. J., Reimer, R. A. Diet-induced changes in maternal gut microbiota and metabolomic profiles influence programming of offspring obesity risk in rats. Sci. Rep. 6, 20683 (2016).
74. Delzenne, N. M., Cani, P. D., Daubioul, C., Neyrinck, A. M. Impact of inulin and oligofructose on gastrointestinal peptides. Br. J. Nutr. 93, S157-S161 (2005).
75. Cani, P. D., et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 90, 1236-1243 (2009).
76. Parnell, J. A., Reimer, R. A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 89, 1751-1759 (2009).
77. Devine, D. A., Marsh, P. D. Prospects for the development of probiotics and prebiotics for oral applications. J. Oral Microbiol. http://dx.doi.org/10.3402/jom.v1i0.1949 (2009).
78. van de Pol, M. A., Lutter, R., Smids, B. S., Weersink, E. J., van der Zee, J. S. Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. Allergy 66, 39-47 (2011).
79. Depner, M., et al. Bacterial microbiota of the upper respiratory tract and childhood asthma. J. Allergy Clin. Immunol. 6749, 30710-30712 (2016).
80. Bomar, L., Brugger, S. D., Yost, B. H., Davies, S. S., Lemon, K. P. Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. mBio 7, e01725-15 (2016).
81. Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220-230 (2012).
82. Reid, G., et al. The case in favour of probiotics before, during and after pregnancy: Insights from the first 1, 500 days. Benef. Microbes 7, 353-362 (2016).
83. Kellow, N. J., Coughlan, M. T., Reid, C. M. Metabolic benefits of dietary prebiotics in human subjects: A systematic review of randomised controlled trials. Br. J. Nutr. 111, 1147-1161 (2014).
84. Beserra, B. T. S., et al. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clin. Nutr. 34, 845-858 (2015).
85. Fernandes, R., do Rosario, V. A., Mocellin, M. C., Kuntz, M. G. F., Trindale, E. B. S. M. Effects of inulin-type fructans, galacto-oligosaccharides and related synbiotics on inflammatory markers in adult patients with overweight or obesity: A systematic review. Clin. Nutr. http://dx.doi.org/10.1016/j.clnu.2016.10.003 (2016).
86. Nicolucci, A. C., Reimer, R. A. Prebiotics as a modulator of gut microbiota in paediatric obesity. Ped. Obes. http://dx.doi.org/10.1111/ijpo.12140 (2016).
87. Barengolts, E. Gut microbiota, prebiotics, probiotics, and synbiotics in management of obesity and prediabetes: Review of randomized controlled trials. Endocr. Pract. 22, 1224-1234 (2016).
88. Parnell, J. A., Raman, M., Rioux, K. P., Reimer, R. A. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and metabolic syndrome. Liver Int. 32, 701-711 (2012).
89. Vulevic, J., Juric, A., Tzortzis, G., Gibson, G. R. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J. Nutr. 143, 324-331 (2013).
90. Cani, P. D., et al. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55, 1484-1490 (2006).
91. Verhoef, S. P., Meyer, D., Westerterp, K. R. Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake. Br. J. Nutr. 106, 1757-1762 (2011).
92. Hume, M. P., Nicolucci, A. C., Reimer, R. A. Prebiotic supplementation improves appetite in children with overweight and obesity: A randomized controlled trial. Am. J. Clin. Nutr. http://dx.doi.org/10.3945/ajcn.116.140947 (2017).
93. Schmidt, K., et al. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl.) 232, 1793-1801 (2015).
94. Sherwin, E., Rea, K., Dinan, T. G., Cryan, J. F. A gut (microbiome) feeling about the brain. Curr. Opin. Gastroenterol. 32, 96-102 (2016).
95. Kim, Y. Y., et al. The effect of chicory fructan fiber on calcium absorption and bone metabolism in Korean postmenopausal women. Nutr. Sci. 7, 151-157 (2004).
96. Holloway, L., et al. Effects of oligofructose-enriched inulin on intestinal absorption of calcium and magnesium and bone turnover markers in postmenopausal women. Br. J. Nutr. 97, 365-372 (2007).
97. McCabe, L., Britton, R. A., Parameswaran, N. Prebiotic and probiotic regulation of bone health: Role of the intestine and its microbiome. Curr. Osteoporos. Res. 13, 363-371 (2015).
98. Firmansyah, A., et al. Fructans in the first 1000 days of life and beyond, and for pregnancy. Asia Pac. J. Clin. Nutr. 25, 652-675 (2016).
99. Abrams, S. A., et al. A combination of prebiotic short-and long-chain inulin type fructans enhances calcium absorption and bone mineralization in young adolescents. Am. J. Clin. Nutr. 82, 471-476 (2005).
100. Kano, M., et al. Consecutive intake of fermented milk containing Bifidobacterium breve strain Yakult and galacto-oligosaccharides benefits skin condition in healthy adult women. Biosci. Microbiota Food Health 32, 33-39 (2013).
101. Miyazaki, K., Masuoka, N., Kano, M., Iizuka, R. Bifidobacterium fermented milk and galacto-oligosaccharides lead to improved skin health by decreasing phenols production by gut microbiota. Benef. Microbes 5, 121-128 (2014).
102. Cuello-Garcia, C. A., et al. World Allergy Organization-McMaster University guidelines for allergic disease prevention (GLAD-P): Prebiotics. World Allergy Organ. J. 9, 10 (2016).
103. Osborn, D. A., Sinn, J. K. Prebiotics in infants for prevention of allergy. Cochrane Database Syst. Rev. 3, CD006474 (2013).
104. Dang, D., et al. Meta-analysis of probiotics and/or prebiotics for the prevention of eczema. J. Int. Med. Res. 41, 1426-1436 (2013).
105. Boyle, R. J., et al. Prebiotic-supplemented partially hydrolysed cow's milk formula for the prevention of eczema in high-risk infants: A randomized controlled trial. Allergy 71, 701-710 (2016).
106. Ghouri, Y. A., et al. Systematic review of randomized controlled trials of probiotics, prebiotics and synbiotics in inflammatory bowel disease. Clin. Exp. Gastroenterol. 7, 473-487 (2014).
107. Coste, I., Judlin, P., Lepargneur, J.-P., Bou-Antoun, S. Safety and efficacy of an intravaginal prebiotic gel in the prevention of recurrent bacterial vaginosis: A randomized double-blind study. Obstet. Gynecol. Int. 2012, 147867 (2012).
108. Giovannini, M., et al. Prebiotic effect of an infant formula supplemented with galacto-oligosaccharides: Randomized multicenter trial. J. Am. Coll. Nutr. 33, 385-393 (2014).
109. Radke, M., et al. Starter formula enriched in prebiotics and probiotics ensures normal growth of infants and promotes gut health: A randomized clinical trial. Pediatr. Res. 81, 622-631 (2016).
110. Martinez, R. C. R., Bedani, R., Saad, S. M. I. Scientific evidence for the health effects attributed to the consumption of probiotics and prebiotics: An update for current perspectives and future challenges. Br. J. Nutr. 114, 1993-2015 (2015).
111. Valdez, Y., Brown, E. M., Finlay, B. B. Influence of the microbiota on vaccine effectiveness. Trend. Immunol. 35, 526-537 (2014).
112. Lohner, S., Kullenberg, D., Antes, G., Decsi, T., Meerpohl, J. J. Prebiotics in healthy infants and children for prevention of acute infectious diseases: A systematic review and meta-analysis. Nutr. Rev. 8, 523-531 (2014).
113. Chatchatee, P., et al. Effects of growing-up milk supplemented with prebiotics and LCPUFAs on infections in young children. J. Ped. Gastroenterol. Nutr. 58, 428-437 (2014).
114. Luoto, R., et al. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: A randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 133, 405-413 (2014).
115. Armanian, A. M., et al. The effect of neutral oligosaccharides on reducing the incidence of necrotizing enterocolitis in preterm infants: A randomized clinical trial. Int. J. Prev. Med. 5, 1387-1395 (2014).
116. Silk, D. B., Davis, A., Vulevic, J., Tzortzis, G., Gibson, G. R. Clinical trial: The effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Alim. Pharm. Ther. 29, 508-518 (2009).
117. Drakoularakou, A., Tzortzis, G., Rastall, R. A., Gibson, G. R. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea. Eur. J. Clin. Nutr. 64, 146-152 (2010).
118. Christodoulides, S., et al. Systematic review with meta-analysis: Effect of fibre supplementation on chronic idiopathic constipation in adults. Aliment. Pharmacol. Ther. 44, 103-116 (2016).
119. Closa-Monasterolo, R., et al. The use of inulin-type fructans improves stool consistency in constipated children. A randomised clinical trial: Pilot study. Int. J. Food Sci. Nutr. 8, 1-11 (2016).
120. Vulevic, J., Drakoularakou, A., Yaqoob, P., Tzortzis, G., Gibson, G. R. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am. J. Clin. Nutr. 88, 1438-1446 (2008).
121. Matsuki, T., et al. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat. Commun. 7, 11939 (2016).
122. Marques, T. M., et al. Programming infant gut microbiota: Influence of dietary and environmental factors. Curr. Opin. Biotechnol. 21, 149-156 (2010).
123. Blaser, M. J. Antibiotic use and its consequences for the normal microbiome. Science 352, 544-545 (2016).
124. Rogler, G., Zeitz, J., Biedermann, L. The search for causative environmental factors in inflammatory bowel disease. Dig. Dis. 34, 48-55 (2016).
125. Griffin, N. W., et al. Prior dietary practices and connections to a human gut microbial metacommunity alter responses to diet interventions. Cell Host Microbe 21, 84-96 (2017).
126. Stevens, C. E., Hume, I. D. Contributions of microbes in vertebrate gastrointestinal tract to production and conservation of nutrients. Physiol. Rev. 78, 393-427 (1998).
127. Respondek, F., et al. Short-chain fructooligosaccharides influence insulin sensitivity and gene expression of fat tissue in obese dogs. J. Nutr. 138, 1712-1718 (2008).
128. Apanavicius, C. J., et al. Fructan supplementation and infection affect food intake, fever, and epithelial sloughing from salmonella challenge in weanling puppies. J. Nutr. 137, 1923-1930 (2007).
129. Gouveia, E. M. M. F., et al. Action of phosphorylated mannanoligosaccharides on immune and hematological responses and fecal consistency of dogs experimentally infected with enteropathogenic Escherichia coli strains. Braz. J. Microbiol. 44, 499-504 (2013).
130. Kanakupt, K., Vester Boler, B. M., Dunsford, B. R., Fahey, G. C. Jr. Effects of short-chain fructooligosaccharides and galactooligosaccharides, individually and in combination, on nutrient digestibility, fecal fermentative metabolite concentrations, and large bowel microbial ecology of healthy adults cats. J. Anim. Sci. 89, 1376-1384 (2011).
131. Verbrugghe, A., et al. Oligofructose and inulin modulate glucose and amino acid metabolism through propionate production in normal-weight and obese cats. J. Nutr. 102, 694-702 (2009).
132. Correa-Matos, N. J., et al. Fermentable fiber reduces recovery time and improves intestinal function in piglets following Salmonella typhimurium infection. J. Nutr. 133, 1845-1852 (2003).
133. Liu, P., et al. Effects of chito-oligosaccharide supplementation on the growth performance, nutrient digestibility, intestinal morphology, and fecal shedding of Escherichia coli and Lactobacillus in weaning pigs. J. Anim. Sci. 86, 2609-2618 (2008).
134. Che, T. M., et al. Mannan oligosaccharide improves immune responses and growth efficiency of nursery pigs experimentally infected with porcine reproductive and respiratory syndrome virus. J. Anim. Sci. 89, 2592-2602 (2011).
135. Halas, V., Nochta, I. Mannan oligosaccharides in nursery pig nutrition and their potential mode of action. Animals 23, 261-274 (2012).
136. Quigley, J. D. III, Drewry, J. J., Murray, L. M., Ivey, S. J. Body weight gain, feed efficiency, and fecal scores of dairy calves in response to galactosyl-lactose or antibiotics in milk replacers. J. Dairy Sci. 80, 1751-1754 (1997).
137. Ghosh, S., Mehla, R. K. Influence of dietary supplementation of prebiotics (mannanoligosaccharide) on the performance of crossbred calves. Trop. Anim. Health Prod. 44, 617-622 (2012).
138. Roodposhti, P. M., Dabiri, N. Effects of probiotic and prebiotic on average daily gain, fecal shedding of Escherichia coli, and immune system status in newborn female calves. Asian-Australas. J. Anim. Sci. 25, 1255-1261 (2012).
139. Baines, D., Erb, S. Characterization of Shiga toxin-producing Escherichia coli infections in beef feeder calves and the effectiveness of a prebiotic in alleviating Shiga toxin-producing Escherichia coli infections. Ir. Vet. J. 66, 17 (2013).
140. Ortiz L. T., Rodríguez, M. L., Alzueta, C., Rebolé, A., Trevinõ, J. Effect of inulin on growth performance, intestinal tract sizes, mineral retention and tibial bone mineralization in broiler chickens. Br. Poult. Sci. 50, 325-332 (2009).
141. Sohail, M. U., et al. Effect of supplementation of prebiotic manna-oligosaccharides and probiotic mixture on growth performance of broilers subjected to chronic heat stress. Poult. Sci. 91, 2235-2240 (2012).
142. Shanmugasundaram, R., Sifri, M., Selvaraj, R. K. Effect of yeast cell product supplementation on broiler cecal microflora species and immune responses during an experimental coccidial infection. Poult. Sci. 92, 1195-1201 (2013).
143. Cho, J. H., Kim, I. H. Effects of lactulose supplementation on performance, blood profiles, excreta microbial shedding of Lactobacillus and Escherichia coli, relative organ weight and excreta noxious gas contents in broilers. J. Anim. Physiol. Anim. Nutr. 98, 424-430 (2014).
144. Roto, S. M., Kwon, Y. M., Ricke, S. C. Applications of in ovo technique for the optimal development of the gastrointestinal tract and the potential influence on the establishment of its microbiome in poultry. Front. Vet. Sci. 3, 63 (2016).
145. Pruszynska-Oszmalek, E., et al. In ovo injection of prebiotics and synbiotics affects the digestive potency of the pancreas in growing chickens. Poult. Sci. 94, 1909-1916 (2015).
146. Bednarczyk, M., et al. Influence of different prebiotics and mode of their administration on broiler chicken performance. Animal 10, 1271-1279 (2016).
147. Li, P., et al. Dietary supplementation of short-chain fructooligosaccharides influences gastrointestinal microbiota composition and immunity characteristics of Pacific white shrimp. Litopenaeus vannamei, cultured in a recirculating system. J. Nutr. 137, 2763-2768 (2007).
148. Hoseinifar, S. H., Khalili, M., Rostami, H. K., Esteban, M. Á. Dietary galactooligosaccharide affects intestinal microbiota, stress resistance, and performance of Caspian roach (Rutilus rutilus) fry. Fish Shellfish Immunol. 35, 1416-1420 (2013).
149. Hoseinifar, S. H., Soleimani, N., Ringø, E. Effects of dietary fructo-oligosaccharide supplementation on the growth performance, haemato-immunological parameters, gut microbiota and stress resistance of common carp (Cyprinus carpio) fry. Br. J. Nutr. 112, 1296-1302 (2014).
150. Morgan, L. M., Coverdale, J. A., Froetschel, M. A., Yoon, I. Effect of yeast culture supplementation on digestibility of varying forage quality in mature horses. J. Equine Vet. Sci. 27, 260-265 (2007).
151. Respondek, F., Goachet, A. G., Julliand, V. Effects of dietary short-chain fructooligosaccharide on the intestinal microflora of horses subjected to a sudden change in diet. J. Anim. Sci. 86, 316-323 (2008).
152. Respondek, F., Myers, K., Smith, T. L., Wagner, A., Geor, R. J. Dietary supplementation with short-chain fructooligosaccharides improves insulin sensitivity in obese horses. J. Anim. Sci. 89, 77-83 (2011).
153. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific Opinion on the substantiation of a health claim related to "native chicory inulin" and maintenance of normal defecation by increasing stool frequency pursuant to Article 13.5 of Regulation (EC) No 1924/2006. EFSA https://www.efsa.europa.eu/en/efsajournal/pub/3951 (2015).
154. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Guidance on the preparation and presentation of an application for authorisation of a novel food in the context of Regulation (EU) 2015/2283. EFSA J. 14, 4594-4624 (2016).
155. U.S. Food and Drug Administration. Draft guidance for industry: Dietary supplements: New dietary ingredient notifications and related issues. FDA http://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/dietarysupplements/ucm257563.htm (2016).
156. U.S. Food and Drug Administration. Changes to the nutrition factors label. FDA http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm385663.htm (2014).